Viewing Study NCT04997902


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:24 AM
Study NCT ID: NCT04997902
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2021-07-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Sponsor: Kura Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module